United Kingdom
The U.K.’s National Health Service (NHS) covers fertility treatment for people seeking treatment, with the number of covered treatments varying based on age. However, local municipalities control the administration of this coverage, meaning that criteria for who can receive the treatment varies drastically across regions. For example, guidelines say that IVF should be available to people until the age of 42, but an investigation by BBC revealed that 80% of areas in the U.K. fail to offer treatment up to that age cutoff. Similarly, while the NHS suggests coverage of up to three cycles of IVF, some municipalities offer only one cycle, while others only cover the treatment in “exceptional circumstances.”
What’s more, studies have found inequalities in the NHS’s fertility coverage: Compared to white women, Black women have poorer outcomes from treatment and receive fewer rounds of IVF. LGBTQIA+ people also face discrimination: until July 2022, same-sex couples of two people assigned female at birth had to undergo six rounds of IUI—paid out-of-pocket—before they could receive funding for IVF.
Employers with employees in the United Kingdom can play an important role in reducing some of the inequities that exist in the current NHS coverage. Culturally-humble fertility care connects U.K. employees to providers with similar backgrounds and lived experiences, ensuring that Black and LGBTQIA+ people receive the same level of support as their white counterparts. Similarly, employers can provide additional financial support in the form of reimbursements for fertility care to extend coverage beyond the NHS’ limits.
Ireland
Currently, Ireland is the only country in the European Union that doesn’t offer state funding for fertility treatments. While the Minister of Health announced in April 2022 that funding will be made available for IVF treatments starting in 2023, it’s unclear how much coverage people will be able to get, and what the eligibility criteria will be. It’s also not the first time that the government said they would begin offering funding—the government first committed to covering infertility treatments in 2019, but no funding emerged from the declaration.
While the country waits for additional clarity around state funding, Irish people seeking fertility treatments still pay completely out-of-pocket. One round of IVF can range from €4,000-6,500, and intracytoplasmic sperm injections (ICSI), commonly used to address male factor infertility, can run upwards of €5,000.
In a country with such uncertainty around national IVF funding, employer-sponsored fertility reimbursements can give employees opportunities to start their families that wouldn’t be financially accessible otherwise.
New Zealand & Australia
New Zealand offers public funding for IVF treatments, but in order to qualify, people must meet a long list of criteria, including an infertility diagnosis, which often prevents lesbian women from accessing care. Couples that have unexplained infertility—infertility not stemming from diagnosable conditions like endometriosis, for example—are likely to be denied public funding. The New Zealand government estimates that 45% of applications for publicly-funded treatment were denied because of unexplained fertility.
Australian funding operates under a rebate system, where people who have government-sponsored insurance can receive coverage for part of their fertility treatment, as well as some of the cost of genetic testing. However, they often do not cover related services, like egg collection, meaning that people may have significant out-of-pocket expenses or need to rely on private insurance for additional coverage.
Providing Australian and New Zealander employees with financial resources to compensate for gaps in care can make a powerful impact on their family journey. Companies can also offer virtual appointments with fertility awareness specialists and reproductive endocrinologists, as well as clinically-vetted content, to empower employees to take control of their fertility journey.
India
Similar to Americans, Indian people often have limited—or nonexistent—coverage for fertility treatments through national or employer-sponsored healthcare. What’s more, misinformation around fertility abounds in the country, with 97% of Indian women believing that a history of pill intake is associated with infertility.
If people decide to seek fertility treatment, they often have to sift through unregulated clinics to find those offering high-quality services. The growth of ART clinics in India is one of the highest in the world, thanks in part to medical tourism. Until the end of 2021, clinics were not regulated or supervised by the government, raising medical and legal concerns. While regulation increased with the passing of the Assisted Reproductive Technology Regulation Bill, finding a reputable fertility clinic can often be an overwhelming process.
As employers look to support Indian employees on their fertility journeys, providing employees with access to a vetted network of fertility clinics can be beneficial. For those looking to understand their fertility better, virtual appointments with Indian fertility specialists, as well as access to clinically-vetted content, is a powerful way to combat misinformation and ensure employees are empowered as they embark on their fertility journeys.
How Maven helps support global employees
Maven is the leading global digital health platform for reproductive and family health that helps companies provide high-quality, comprehensive support for their global employees as they pursue parenthood and beyond. Our holistic care model offers wraparound fertility support through personalized care teams, dedicated care advocacy, and evidence-based care management programs to help drive better outcomes for your employees.
To learn more about how Maven supported a U.K.-based member on her fertility journey, read Catherine’s story. And to see Maven’s global platform in action, contact us to schedule a demo today.
.jpeg)
.jpeg)
.svg)
.jpeg)
